Trial Profile
Monocenter, double blinded, exploratory, randomized, study investigating the influence of Pasireotide on the hormonal activity of Pheochromocytoma - proof of concept study.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 13 Jul 2011
Price :
$35
*
At a glance
- Drugs Pasireotide (Primary)
- Indications Paraganglioma; Phaeochromocytoma
- Focus Therapeutic Use
- 13 Jul 2011 New trial record